FDA Approves Unknown Drug — SAGENT PHARMS INC

On September 30, 2011, Sagent Pharmaceuticals received FDA approval for ANDA090109, a move that underpins the company’s strategy to expand its product portfolio and drive future revenue growth. This regulatory milestone highlights Sagent's increasing influence in the generic pharmaceutical market following its acquisition of Par Pharmaceutical.